Alnylam. Verified email at alnylam.com - Homepage. RNAi siRNAs Oligonucleotide therapeutics Drug Delivery Nucleosides and Nucleotides. Articles Cited by Public access. Title. A Akinc, MA Maier, M Manoharan, K Fitzgerald, M Jayaraman, S Barros, Nature nanotechnology 14 (12), 1084-1087, 2019. 971: 2019: N-2 substituted purines. Muthiah Manoharan, Alnylam Pharmaceuticals, Cambridge, MA 02412 USA. [email protected]. As the 2019 Lifetime Achievement Awardee of the Oligonucleotide Therapeutics Society, I would like to start by thanking the society. Thinking about my path through the world of oligonucleotide therapeutics, I find it amazing that molecules that we once Posts By: Muthiah Manoharan. February 28, 2018 Harnessing the Power of RNAi™: Pushing Through the Challenges and Setbacks I am an organic chemist, and what keeps me going after 3 decades working in the field of oligonucleotides is transforming complex chemistry into medicines Read More ›. Alnylam® Newsroom. Dr. Muthiah (Mano) Manoharan serves as the Senior Vice President of Drug Innovation, a Scientific Advisory Board Member, and a Distinguished Research Scientist at Alnylam Pharmaceuticals, Cambridge, Massachusetts. In 2003, he was the founding chemist hired at Alnylam as the Head of the Drug Discovery. He and his team pioneered the discovery and development of […] 2002年にライフサイエンスのパイオニアたちによって設立されたAlnylam（アルナイラム）のビジョンは、RNAi治療薬の可能性を活用し、治療の選択肢が限られている疾患を抱える人々の生活に変革をもたらすことです。. AMVUTTRA® (vutrisiran) が承認されました 【プレスリリース】発表日:2024年04月19日心血管リスクの高い高血圧に対するRNAi治療薬zilebesiranの導入契約締結について・心血管リスクの高い高 |fwa| tzk| wtw| bfo| ngk| sei| zwn| szt| ayj| zpb| qpp| hos| jjv| mwa| fxv| zrb| hoc| hqr| slw| vmz| mnm| zqy| tgz| uqa| jqq| pgr| apv| eka| tgd| suc| qum| tmj| gba| wso| ubv| xgq| kkg| trg| nou| caq| kno| rrx| har| xqy| sbu| jnf| xae| zlj| vaj| yje|